INS and Hypoglycemia: Through structural modifications that impart glucose-responsive capabilities, controlled release of insulin can be achieved, avoiding side effects like hypoglycemia.708 Unlike systems relying on endogenous stimuli such as pH and glucose levels, ultrasound-triggered systems are controlled by exogenous active signals to release drugs on demand.